Loading...
NPI 1619964236 · Niskayuna, NY · Hematology & Oncology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Rana Jacob is a hematology & oncology physician provider located in Niskayuna, New York. This profile covers 32 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Rana Jacob |
| Address | 2125 River Road |
| City | Niskayuna |
| State | NY |
| ZIP | 12309 |
| Taxonomy | Hematology & Oncology Physician |
| NPI Enumerated | September 29, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $601.1K |
| Medicaid | $720 |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
32 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | 8,640 | $20 | $155.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,420 | $90 | $131.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 420 | $140 | $58.7K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 8,800 | $10 | $52.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 42,000 | $1 | $42K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 350 | $100 | $35.6K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,660 | $10 | $34K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 390 | $60 | $23.5K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 2,180 | $10 | $17.5K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 810 | $10 | $8.1K |
Showing 1–10 of 32
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 32 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
32 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0897 | 63 | 490 | 2,820 | $20 | $84.4K |
| J1439 | 42 | 90 | 39,750 | $1 | $42K |
| J0885 | 14 | 50 | 2,530 | $10 | $26.1K |
| Q5106 | 2 | 30 | 3,320 | $10 | $23.1K |
| 99214 | 278 | 30,450 | 90 | $100 | $19K |
| 96413 | 38 | 380 | 110 | $110 | $18.1K |
| 99213 | 3,553 | 31,440 | 80 | $70 | $12.1K |
| 99215 | 150 | 8,280 | 40 | $140 | $10.1K |
| 84443 | 1,388 | 1,510 | 90 | $20 | $7.9K |
| 96365 | 283 | 610 | 80 | $60 | $7.7K |
Showing 1–10 of 32
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 40 | $20 | $650 |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 210 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 12,963 | 16,550 | 220 | $90 | $186.8K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 3,079 | 5,090 | 450 | $10 | $35.9K |
Other providers in the same ZIP code as Rana Jacob, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Patrick Parisi | NY | Cardiovascular Disease Physician | $187.6K | $59.7K |
| Sasi Cheruvu | NY | Diagnostic Radiology Physician | $241.7K | $590 |
| Jessica Sacks | NY | Medical Physician Assistant | $237.3K | $0 |
| Thomas Cooney | NY | Physical Therapist | $235.4K | $0 |
| Peter Rienzi | NY | Internal Medicine Physician | $221.1K | $0 |
| Steven Giovannone | NY | Clinical Cardiac Electrophysiology Physician | $164.8K | $1.7K |
| Naseer Chowdhrey | NY | Neurology Physician | $123.9K | $19.1K |
| Aakash Garg | NY | Interventional Cardiology Physician | $134K | $0 |
| Shaheen Rahman | NY | Urology Physician | $119.8K | $1 |
| Shailesh Patel | NY | Pulmonary Disease Physician | $105K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.